Ureteral Stone Clinical Trials

11 recruitingLast updated: July 25, 2026

There are 11 actively recruiting ureteral stone clinical trials across 4 countries. Studies span Not Applicable, Phase 2, Phase 4. Top locations include Banī Suwayf, Beni Suweif Governorate, Egypt, Chicago, Illinois, United States, Indianapolis, Indiana, United States. Updated daily from ClinicalTrials.gov.


Ureteral Stone Trials at a Glance

11 actively recruiting trials for ureteral stone are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Banī Suwayf, Chicago, and Indianapolis. Lead sponsors running ureteral stone studies include Beni-Suef University, Northwestern University, and Chung Jing Wang.

Browse ureteral stone trials by phase

Treatments under study

About Ureteral Stone Clinical Trials

Looking for clinical trials for Ureteral Stone? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ureteral Stone trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ureteral Stone clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Stone and Laser Therapies Post-Market Study (SALT)

Benign Prostate Hypertrophy(BPH)Ureteral Stones, Kidney StonesCalculi, Urinary+2 more
Boston Scientific Corporation238 enrolled5 locationsNCT06982235
Recruiting
Not Applicable

Patient Positioning for Treatment of Proximal Ureteral Stones

Ureteral Stone
Icahn School of Medicine at Mount Sinai54 enrolled1 locationNCT07601932
Recruiting
Not Applicable

Initial Drainage Method and Flexible Ureteroscopy Outcomes in Calculous Anuria

Acute Kidney InjuryObstructive UropathyCalculous Anuria+1 more
Beni-Suef University90 enrolled3 locationsNCT07627880
Recruiting
Phase 2

L-Citrulline Versus Tamsulosin for Medical Expulsive Therapy of Distal Ureteral Stones

UrolithiasisUreteral CalculiDistal Ureteral Stone
Beni-Suef University120 enrolled1 locationNCT07617909
Recruiting
Phase 2

Intravesical Aminophylline to Facilitate Ureteroscopic Access in Children With Distal Ureteral Stones.

Ureteral CalculiPediatric UrolithiasisDistal Ureteral Stone
Beni-Suef University60 enrolled1 locationNCT07617896
Recruiting
Not Applicable

Evaluating Postoperative Pain After Ureterorenoscopy.

Ureteral Stones
Lukas J Hefermehl60 enrolled1 locationNCT07283003
Recruiting
Not Applicable

Access Sheath and Stent Trial

Kidney StoneUreteral Stone
University of Michigan184 enrolled1 locationNCT07297953
Recruiting
Not Applicable

Ureteroscopy With High-powered Holmium:Yag Laser Lithotripsy With and Moses On or Moses Off

Kidney StoneUreteral Stone
Northwestern University150 enrolled1 locationNCT06346483
Recruiting
Not Applicable

High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy

Kidney StoneUreteral Stone
Northwestern University168 enrolled1 locationNCT05006937
Recruiting
Not Applicable

UPURS Trial for Patient-centered Management of Symptomatic Obstructing Stones

Ureteral Stone
University of California, San Francisco100 enrolled1 locationNCT05715086
Recruiting
Phase 4

Efficacy of Highly Selective-a-1A-Adrenoceptor Antagonist Silodosin in Expulsive Therapy of Lower Ureteral Stones: A Randomized Controlled Study

radiopaque lower ureteral stones >5mm
Chung Jing Wang45 enrolled1 locationACTRN12611000571976